Wellington Management Group LLP Sells 2,496,123 Shares of agilon health, inc. (NYSE:AGL)

Wellington Management Group LLP lowered its position in shares of agilon health, inc. (NYSE:AGL - Free Report) by 4.5% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 52,882,595 shares of the company's stock after selling 2,496,123 shares during the period. Wellington Management Group LLP owned about 12.84% of agilon health worth $207,829,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. J.Safra Asset Management Corp grew its position in agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock worth $27,000 after acquiring an additional 3,625 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in agilon health during the 3rd quarter worth $28,000. City State Bank bought a new stake in agilon health during the 3rd quarter worth $52,000. CWM LLC grew its position in agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company's stock worth $59,000 after acquiring an additional 7,288 shares during the last quarter. Finally, Nisa Investment Advisors LLC bought a new stake in shares of agilon health in the 2nd quarter valued at about $60,000.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on AGL shares. Bank of America lowered agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price target on the stock. in a research report on Wednesday, October 2nd. Barclays reduced their price target on agilon health from $5.00 to $2.00 and set an "underweight" rating on the stock in a research report on Monday, November 11th. Stifel Nicolaus reduced their price target on agilon health from $7.00 to $2.00 and set a "hold" rating on the stock in a research report on Tuesday, November 12th. JMP Securities lowered agilon health from an "outperform" rating to a "market perform" rating in a research report on Monday, November 11th. Finally, TD Cowen reduced their price target on agilon health from $6.00 to $2.00 and set a "hold" rating on the stock in a research report on Monday, November 11th. Three equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $5.20.

Insider Transactions at agilon health

In related news, CEO Steven Sell acquired 20,000 shares of the stock in a transaction dated Thursday, September 12th. The stock was purchased at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the purchase, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. This trade represents a 42.03 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 3.20% of the company's stock.

agilon health Stock Up 3.2 %

AGL stock traded up $0.07 during trading on Monday, reaching $2.24. 3,477,872 shares of the stock were exchanged, compared to its average volume of 4,880,998. The firm's 50 day moving average is $2.57 and its 200 day moving average is $4.51. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $13.76. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a market cap of $922.92 million, a P/E ratio of -2.38 and a beta of 0.52.

agilon health (NYSE:AGL - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period last year, the company posted ($0.06) earnings per share. As a group, research analysts forecast that agilon health, inc. will post -0.5 EPS for the current year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.